Met Life Investment Management, LLC Tyra Biosciences, Inc. Transaction History
Met Life Investment Management, LLC
- $14.7 Billion
- Q1 2024
A detailed history of Met Life Investment Management, LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 7,702 shares of TYRA stock, worth $128,623. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,702Holding current value
$128,623% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding TYRA
# of Institutions
77Shares Held
32.4MCall Options Held
600Put Options Held
3.7K-
Boxer Capital, LLC San Diego, CA6.45MShares$108 Million5.5% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$77.8 Million2.29% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$73.6 Million79.77% of portfolio
-
Nextech Invest Ag4.06MShares$67.7 Million12.44% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA1.99MShares$33.2 Million3.43% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $701M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...